Neurobiology of Depression - Craviso Flashcards

1
Q

What areas of the brain are involved in depression?

A

Those that are important in the regulation of mood, emotional expression, reward processing, attention, motivation, stress responses and neuro-vegetative function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List specific areas of the brain involved in depression.

A
  1. hypothalamus
  2. hippocampus
  3. cingulate gyrus
  4. amygdala
  5. prefrontal cortex
  6. ventral striatum
    Hypothalamus, cingulate gyrus, amygdala together make up the limbic system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What types of technology have been used in research to identify areas of the brain that are abnormal with depression?

A
  1. Positron emission tomography or PET scan - used to visualize activity-dependent changes in blood flow, tissue metabolism or biochemical activity
  2. Magnetic resonance imaging or MRI - detailed spatial images of the brain at any location and orientation
  3. post mortem analysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In research, what types of structural abnormalities of the brain have been found in those with depression?

A
  1. reduced number of synapses and glial cells
  2. reduced neuronal size
  3. reduced gray matter volume in hippocampus, cingulate gyrus, prefrontal cortex and ventral striatum. may be reduced or increased in amygdala
  4. reduced cell count and cell markers in the hippocampus, cingulate gyrus, prefrontal cortex, amygdala and ventral striatum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What kinds of functional abnormalities in the brain have been found in those with depression?

A
  1. PET images show increased blood flow to the amygdala and prefrontal cortex
  2. increased metabolic activity in the anterior cingulate cortex and the rostral anterior cingulate cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Increased metabolic activity in the rostral anterior cingulate cortex in depressed individuals can be used as a marker for what?

A

Can be used as a marker of prediction of how well an individual will respond to pharmacologic treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Initially, it was found that Reserpine and Iproniazid were drugs that affected depression. What were these drugs used for and how are they similar?

A

Reserpine was used to control hypertension and Iproniazid was used to treat tuberculosis. Reserpine induced depression and Iproniazid elevated mood. The basis for the effect on depression had to do with their MOA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe Reserpine.

A
  1. an alkaloid derived from rauwolfia plant
  2. inhibits vesicualr storage of biogenic amines (NE,D,5HT) resulting in their intraneuronal metabolism by monoamine oxidase
  3. causes depletion of neuronal stores of biogenic amines which led to depression in some patients using it
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe Iproniazid.

A
  1. inhibits intraneuronal monoamine oxidase

2. causes higher levels of biogenic amines causing some patients using it to have elevated moods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What theory about depression came out of the studies of Reserpine and Iproniazid?

A

The monoamine hypothesis of depression - dysfunction of monoamine neurotransmitter systems that cause a deficit of biogenic amines (particularly NE and 5HT) causes depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

The monoamine hypothesis of depression is consistent with what?

A

The biogenic amines found to be correlated with depression are part of the neurotransmitter systems in key areas of the brain that regulate mood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are some weaknesses of the monoamine hypothesis of depression?

A
  1. depression includes a constellation of changes in addition to mood - such as sleep patterns, appetite and cognitive function. it is unrealistic to assume a single drug can restore balance among all the interacting neuronal networks involved
  2. about 60-70% of patients resound in the short term to antidepressants and total remission of symptoms occurs in about 50% - but not all depressed patients
  3. most clinically used antidepressants rapidly increase biogenic amine levels whereas the therapeutic effects are delayed by several weeks - antidepressant effects more likely due to adaptive changes in CNS that take time to develop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What types of adaptive changes occur with treatment via antidepressants?

A
  1. long term enhancement of monoamine neurotransmission including desensitization of auto receptors (increases release of the monoamine) and increased activity of certain post synaptic monoamine receptors
  2. these changes are thought to contribute to the antidepressant effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is another theory of the cause of depression?

A

The neurotrophic hypothesis - depression is associated with loss of neurotrophic support. Use of antidepressants actually increases neurogenesis and synaptic connectivity in cortical areas such as the hippocampus (site of neural plasticity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What findings support the neurotrophic hypothesis?

A
  1. currently available antidepressants cause a slow increase in nerve growth factor expression (BDNF) that is critical in the regulation of neural plasticity, resilience and neurogenesis
  2. evidence suggests that antidepressants are involved in long term adaptive changes that involve synaptogenesis
    * BDNF stands for brain derived neurotrophic factor *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What other findings lend support to the neurotrophic hypothesis?

A

In the hippocampus:

  1. there is atrophy of neurons in response to persistently elevated levels of cortisol
  2. there is death of neurons with severe and prolonged stress leading to damage of the hippocampus
  3. chronic stress decreases BDNF
  4. it was found that glucocorticoids cause inhibition of BDNF in a depressed state that can be reversed in a treated state
17
Q

Based on the association between synaptogenesis and the neurotrophic hypothesis it is thought that a drug that could cause long term potentiation (increases synaptogenesis) can alleviate the symptoms of depression more quickly. What findings support this?

A
  1. A single dose of an NMDA glutamate receptor antagonist called ketamine delivered via intravenous infusion alleviated depressive symptoms within hours
  2. it also reduced suicidal ideation
  3. ketamine was found to be effective for patients who failed to respond to two or more conventional antidepressants
  4. found to be effective for treating bipolar disorder
  5. effects of ketamine lasted for several days to a week
18
Q

What is a side effects of ketamine?

A

Causes dissociation.

19
Q

If ketamine is an NMDA receptor antagonist then how does it cause synaptogenesis?

A

The mechanism is not known but it is thought that it may rapidly and transiently increase glutamate neurotransmission possibly by inhibition of tonically active GABAergic interneurons leading to increased levels of BDNF and AMPA receptors causing LTP type effects.

20
Q

What are some drawbacks of ketamine?

A
  1. has poor biovailability when taken orally
  2. extent to which repeated infusion will be effective is not yet known
  3. safety of repeated use is not yet determined
  4. repeated use has the potential for abuse
21
Q

What is the new, prevailing theory about depression?

A

The new hypothesis is that depression is not caused by specific neurotransmitters. Mental disorders are thought to be circuit disorders and so it is now thought that synaptogeneis and neuroplasticity play a big role.

22
Q

What is a new type of therapy that may be available for treating refractory depression, OCD and Parkinson’s disease?

A

Deep brain stimulation - electric stimulation that quiets the overactive regions of the brain - alters excitability by affecting neural networks. Current therapies are invasive but new non-invasive therapies are being developed